Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

Deovita is a subscription-based telemedicine app for Brazilian users, providing 24/7 access to medical specialists and veterinary care via video consultation.

The App DNA

What makes this app unique?

The platform removes the financial friction of private medical consultations for families by providing a flat-rate monthly subscription model.

For Families and individuals in Brazil seeking affordable, on-demand access to medical specialists and veterinary advice.

What does it look like?

Key features

Telemedicine 24/7standard

Unlimited video consultations with general practitioners and pediatricians, serving as the primary subscription gate.

Telepetedge

Virtual veterinary consultations for dogs and cats, reducing churn by bundling pet care with human health services.

Discount Networkedge

Up to 80% off private consultations and pharmacy discounts, incentivizing long-term retention.

How much does it cost?

subscriptionIndividual plan at R$ 19.90/monthFamily plan (up to 4 dependents) at R$ 29.90/month

Subscription model anchored at R$ 19.90/month with a 12-month loyalty commitment and additional copayments for specific consultations.

Velocity

Maintenance developmentperformanceUX improvementsShow more...

Deovita is currently in a maintenance phase, with only two releases identified over the last several months. The latest release occurred 97 days ago, and the overall cadence averages roughly one update every 3 months. Development activity is limited to minor technical adjustments, such as icon updates and deep-linking, with no evidence of new feature development or live-ops content. The current release pattern suggests a focus on basic stability rather than active product expansion.

See all version history

Who built it?

Centro de Diagnostico Costa e Cavalcante Ltda

1 app tracked · Medical

Explore the full publisher profile

User Sentiment

What do users think recently?

How are ratings & reviews evolving?

App Store
5.00 · 1
Google Play
0.00 · 0

Not enough recent reviews to extract reliable themes yet.

Read the full review analysis

Competition

Competitive landscape for Deovita

How's the Medical market?

Deovita currently ranks #116 in the Brazilian Medical category. The lack of recent major feature updates suggests a focus on maintaining existing infrastructure rather than aggressive market share expansion.

Read the market outlook

The rivals identified

Unlock the deeper market read.

Access the full report for free

The Analyst's Read

Key takeaways for Deovita

Where is it heading?

The Brazilian telemedicine market is consolidating, and Deovita's focus on low-cost family bundles provides a defensible position against premium insurers. However, the lack of recent feature updates leaves the platform exposed to more agile competitors who may introduce better-integrated social or referral features.

  • The maintenance-only release cadence suggests a focus on operational stability rather than rapid feature expansion, which limits the potential for new user acquisition.

The SWOT

Core Strengths
  • Telepet bundle creates household-level retention
  • Pharmacy discount network increases subscription utility
Critical Frictions 2 weaknesses inside
Growth Levers
  • Untapped market for affordable family health plans
Market Threats 1 threat identified

Next best moves

1 Invest

Ship a referral program because the current user base lacks growth loops → increase organic install velocity

The counter-intuitive read

The lack of aggressive feature development is a…

Read the full take

Since the last report: Deovita has refined its market positioning to emphasize specific pharmacy discount metrics and family-plan affordability, while updating its SWOT analysis to acknowledge increased competitive vulnerability. The core product development remains stagnant, with no new features or updates reported.

Bottom line

Deovita maintains a stable position by serving the underserved Brazilian market with affordable, bundled health access. The PM should prioritize feature expansion over maintenance to defend this niche against potential new entrants, as the current lack of development leaves the platform vulnerable.

Unlock 2 critical frictions, 1 market threat and the analyst’s take.

Access the full report for free

Sources

  1. [1] App Store listing

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Deovita, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

Deovita has refined its market positioning to emphasize specific pharmacy discount metrics and family-plan affordability, while updating its SWOT analysis to acknowledge increased competitive vulnerability. The core product development remains stagnant, with no new features or updates reported.

added

Expanded Threat and Weakness Profile

improved

Increased Pricing and Discount Transparency

shifted

Refined Value Proposition

Cite this report

Marlvel.ai. “Deovita Intelligence Report.” Updated Aug 31, 2026. https://marlvel.ai/apps/deovita

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0